drugset / Trial / NCT03203564
Study Evaluating ECG Effects, Safety, Tolerability and Pharmacokinetics of Single Doses of Modufolin (Arfolitixorin) in Healthy Volunteers Tetrahydrofolate in Healthy Male Volunteers
RandomizedSingle-groupTriple-blindOther
Summary
The purpose of this study is to evaluating ECG effects, safety, tolerability and pharmacokinetics of single ascending dose of Modufolin® in healthy male volunteers
Timeline
- Start
- 2017-07-04
- Primary completion
- 2017-08-25
- Completion
- 2017-08-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Arfolitixorin | Small molecule | 200 mg/m2 | — |
| Comparator | Arfolitixorin | Small molecule | 350 mg/m2 | — |
| Comparator | Arfolitixorin | Small molecule | 500 mg/m2 | — |
Indications
No indication recorded.